This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Cutis Laxa
Information about Cutis Laxa: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Cutis Laxa
Most recent studies have shown that Cutis Laxa shares some biological mechanisms with aneurysm, aortic-aneurysm, atrophy, blepharoptosis, cicatrix, congenital-abnormality, connective-tissue-diseases, cutis-laxa-acquired-type, dermatologic-disorders, edema, ehlers-danlos-syndrome, eyelid-diseases, hernia, inflammation, marfan-syndrome, pseudoxanthoma-elasticum, pulmonary-emphysema.
Among the many pathways, these few ones have gauged particular interests from scientists studying Cutis Laxa, and have been seen in publications frequently: Aging, Coagulation, Dehiscence, Elastic Fiber Assembly, Excretion, Glycosylation, Granuloma Formation, Inflammatory Response, Localization, Pathogenesis, Phagocytosis, Pigmentation, Proteolysis, Regeneration, Secretion, Senescence, Translation, Transport, Transposition, Wound Healing
Quite a number of genes have been found to play important roles in Cutis Laxa, such as ABCC6, ATP6V0A2, ATP7A, C2, CTSG, EFEMP2, ELANE, ELN, FBLN5, FBN1, FN1, GSN, KCNT1, LOX, MMP12, MMP2, MMP9, PYCR1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.